We found an article that further confirms the potential benefits offered by the ED drugs for Raynaud’s sufferers, particularly when traditional treatments such as vasodilators and topical nitroglycerine-based creams provide insufficient relief or aren’t well tolerated.
Original studies focused on the effectiveness of sildenafil (Viagra) for Raynaud’s disease. The positive results prompted researchers to study newer drugs in the ED class as potential therapies for Raynaud’s, including vardenafil (Levitra) and taldalafil (Cialis) – both drugs appear promising in their ability to reduce the duration and frequency of attacks, and no treatment-related side effects were reported in the studies quoted.
The author is Elaine Moore, a medical technologist and medical writer. Read more at Suite101: http://is.gd/WaBCKD